Global Anti-inflammatory Therapeutics Market 2017-2021

抗炎症薬の世界市場2017-2021

◆タイトル:Global Anti-inflammatory Therapeutics Market 2017-2021
◆商品コード:IRTNTR13531
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年6月14日
◆ページ数:98
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、抗炎症薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、抗炎症薬の世界市場規模及び予測、用途別分析、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Anti-Inflammatory Therapeutics
Inflammation is a part of immune response triggered against harmful stimuli, foreign objects, damaged cells, irritants, and pathogens in the body. The drugs used to treat these symptoms are called anti-inflammatory drugs. It causes the elimination of the initial cause of cell injury, clearance of dead or necrotic cells, and damaged tissue from the site of the inflammatory process and initiates tissue repair.

Technavio’s analysts forecast the global anti-inflammatory therapeutics market to grow at a CAGR of 6.10% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global anti-inflammatory therapeutics market for 2017-2021. To calculate the market size, the report considers sales of branded, off-label, and generic drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Anti-Inflammatory therapeutics market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AbbVie
• Amgen
• Johnson & Johnson
• Pfizer

[Other prominent vendors]
• Boehringer Ingelheim
• Eli Lilly
• Novartis

[Market driver]
• Availability of targeted therapy
• For a full, detailed list, view our report

[Market challenge]
• Complex regulatory approval process for biosimilars
• For a full, detailed list, view our report

[Market trend]
• Emergence of novel anti-inflammatory drugs
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Inflammation: An overview

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Key clinical trial

PART 08: Market segmentation by application
• RA
• Psoriasis
• MS

PART 09: Market segmentation by drug class
• Anti-inflammatory biologicals
• NSAIDs
• Corticosteroids

PART 10: Geographical segmentation
• Anti-inflammatory therapeutics market in Americas
• Anti-inflammatory therapeutics market in EMEA
• Anti-inflammatory therapeutics market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges
• Market drivers
• Market challenges

PART 13: Market trends
• Emergence of novel anti-inflammatory drugs
• Increasing strategic alliances by vendors
• Advent of biosimilars

PART 14: Vendor landscape
• Competitive scenario

PART 15: Key vendor analysis
• AbbVie
• Amgen
• Johnson & Johnson
• Pfizer
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Market segmentation of global autoimmune disease market by drug class
Exhibit 02: Snapshot of drivers and challenges present in the market
Exhibit 03: Global anti-inflammatory therapeutics market snapshot
Exhibit 04: Global anti-inflammatory therapeutics market revenue 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis in global anti-inflammatory therapeutics market
Exhibit 06: Five forces analysis
Exhibit 07: Pipeline snapshot
Exhibit 08: Pipeline landscape
Exhibit 09: Purpose of clinical trial
Exhibit 10: Global anti-inflammatory therapeutics market segmentation based on application
Exhibit 11: Global anti-inflammatory therapeutics market based on application 2016 (%)
Exhibit 12: Risk factors responsible for RA
Exhibit 13: National arthritis prevalence rate in the US 2000-2040
Exhibit 14: Drivers and challenges of global anti-inflammatory RA therapeutics market 2016
Exhibit 15: Global anti-inflammatory RA therapeutics market revenue 2016-2021 ($ millions)
Exhibit 16: Drivers and challenges of global anti-inflammatory psoriasis therapeutics market 2016
Exhibit 17: Global anti-inflammatory psoriasis therapeutics market 2016-2021 ($ millions)
Exhibit 18: Drivers and challenges of global anti-inflammatory MS therapeutics market 2016
Exhibit 19: Global anti-inflammatory MS therapeutics market 2016-2021 ($ millions)
Exhibit 20: Global anti-inflammatory therapeutics market segmentation based on drug class
Exhibit 21: Global anti-inflammatory therapeutics market segmentation based on drug class 2016 (%)
Exhibit 22: Marketed anti-inflammatory biologicals
Exhibit 23: Global anti-inflammatory biologicals therapeutics market 2016-2021 ($ millions)
Exhibit 24: NSAIDs used for the treatment of autoimmune diseases
Exhibit 25: Global anti-inflammatory NSAIDs therapeutics market 2016-2021 ($ millions)
Exhibit 26: Global anti-inflammatory corticosteroid therapeutics market 2016-2021 ($ millions)
Exhibit 27: Global anti-inflammatory therapeutics market based on geography 2016 and 2021 (%)
Exhibit 28: Global anti-inflammatory therapeutics market based on geography 2016-2021 ($ millions)
Exhibit 29: Global anti-inflammatory therapeutics market based on geography 2016-2021 (%)
Exhibit 30: Market scenario in Americas
Exhibit 31: Anti-inflammatory therapeutics market in Americas 2016-2021 ($ millions)
Exhibit 32: Market scenario in EMEA
Exhibit 33: Anti-inflammatory therapeutics market in EMEA 2016-2021 ($ millions)
Exhibit 34: Market scenario in APAC
Exhibit 35: Anti-inflammatory therapeutics market in APAC 2016-2021 ($ millions)
Exhibit 36: Prevalence rate of types of IBD in the US 2015
Exhibit 37: Incidence rate of types of IBD in the US 2015
Exhibit 38: Biologics approvals by the US FDA to treat autoimmune diseases
Exhibit 39: Commonly used off-label anti-inflammatory therapeutics
Exhibit 40: Ongoing clinical trials with JAK inhibitors
Exhibit 41: Competitive structure analysis of global anti-inflammatory therapeutics market 2016
Exhibit 42: Competitive landscape snapshot
Exhibit 43: AbbVie: Key highlights
Exhibit 44: AbbVie: Strength assessment
Exhibit 45: AbbVie: Strategy assessment
Exhibit 46: AbbVie: Opportunity assessment
Exhibit 47: Amgen: Key highlights
Exhibit 48: Amgen: Strength assessment
Exhibit 49: Amgen: Strategy assessment
Exhibit 50: Amgen: Opportunity assessment
Exhibit 51: Johnson & Johnson: Key highlights
Exhibit 52: Johnson & Johnson: Strength assessment
Exhibit 53: Johnson & Johnson: Strategy assessment
Exhibit 54: Johnson & Johnson: Opportunity assessment
Exhibit 55: Pfizer: Key highlights
Exhibit 56: Pfizer: Strength assessment
Exhibit 57: Pfizer: Strategy assessment
Exhibit 58: Pfizer: Opportunity assessment



【掲載企業】

AbbVie, Amgen, Johnson & Johnson, Pfizer, Boehringer Ingelheim, Eli Lilly, and Novartis.

【資料のキーワード】

抗炎症薬

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[抗炎症薬の世界市場2017-2021] (Global Anti-inflammatory Therapeutics Market 2017-2021 / IRTNTR13531)販売に関する免責事項
[抗炎症薬の世界市場2017-2021] (Global Anti-inflammatory Therapeutics Market 2017-2021 / IRTNTR13531)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆